Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on
This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old in the United States every year.
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday approved the injection for infants and children up to 2 years old. It's made by AstraZeneca and is already approved in Canada and Europe. RSV is a cold-like nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies yet so AstraZeneca's shot is expected to fill a critical need. Pfizer and other companies ar...
(CNN) — This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a